Information

2010/01/13

Notice for Large Volume Exercise of the 30th Round of Stock Options

2010/01/08

PharmAsia News reported that China might be the third country in the world to have pirfenidone approved for Idiopathic Pulmoary Fibrosis. “In China, IPF is estimated to affect up to about 400,000 to 500,000 patients every year ……Our company

2010/01/07

Notice for Large Volume Exercise of the 30th Round of Stock Options

2010/01/05

Notice for Large Volume Exercise of the 30th Round of Stock Options

2010/01/04

Notice for Exercise of the 30th Round of Stock Options in December, 2009

2009/12/28

Notice for Large Volume Exercise of the 30th Round of Stock Options

2009/12/21

F647 New Drug Application (NDA) DRAFT In Review By Shanghai Food and Drug Administration

2009/12/07

Notice for Payment for Third-Party Allotment and the Issuance of the 30th Round of Stock Options

2009/11/20

GNI Announces Third-Party Allotment and the Issuance of the 30th Round of Stock Options.

2009/09/29

Schering-Plough Extends Joint Research Program with Shanghai Genomics